{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:11:28Z","timestamp":1761707488152},"reference-count":0,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1997,4,1]]},"DOI":"10.1093\/qjmed\/90.4.277","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T18:38:32Z","timestamp":1027708712000},"page":"277-282","source":"Crossref","is-referenced-by-count":22,"title":["Modelling and costing the consequences of using an ACE inhibitor to slow the progression of renal failure in type I diabetic patients"],"prefix":"10.1093","volume":"90","author":[{"given":"B.","family":"Hendry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","container-title":["QJM"],"original-title":[],"link":[{"URL":"http:\/\/academic.oup.com\/qjmed\/article-pdf\/90\/4\/277\/9909804\/900277.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T23:44:41Z","timestamp":1503531881000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/qjmed\/article-lookup\/doi\/10.1093\/qjmed\/90.4.277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,4,1]]},"references-count":0,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.1093\/qjmed\/90.4.277","relation":{},"ISSN":["1460-2393"],"issn-type":[{"value":"1460-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,4,1]]}}}